Cart
0
Product
Products
(empty)
No products
To be determined
Shipping
$0.00
Total
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart.
There is 1 item in your cart.
Total products
Total shipping
To be determined
Total
New
Reduced price!
View larger
View larger
CGA PS-42:2018
New product
CGA PS-42:2018
CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211More info
This position statement reflects the Compressed Gas Association’s (CGA) consensus position for how the FDA’s regulations for finished pharmaceuticals found in Title 21 of the U.S. Code of Federal Regulations (21 CFR) Parts 201 (labeling), 205 (wholesale distribution), and 210 and 211 (GMPs), should be revised for designated medical gases or combinations thereof. This position is consistent with established and long standing industry practice yielding safe and efficacious designated medical gases and consistent with the Congressional intent in the FDASIA identifying the need for revisions to 21 CFR.
| Author | CGA |
|---|---|
| Editor | CGA |
| Document type | Standard |
| Format | File |
| Edition | 3 |
| Number of pages | 3 |
| Year | 2018 |
| Country | USA |